Posters are bringing up some very interesting ques

Posters are bringing up some very interesting questions regarding how President Trump waffled on his recollection of the treatment he received for Covid-19.

Does anyone find it "interesting" that the Philippine former President also waffled on his treatment after it was made public to be leronlimab?

Does anyone find it "interesting" that leronlimab has been slow walked in the Philippines?

Does anyone find it "interesting" that the Brazil Covid trails were slow walked for a year or so?

Does anyone find it "interesting" that HIV approval has been slow walked for years due to forms not being completed properly?

Does anyone find it "interesting" that India suddenly lost interest in conducting
trials for leronlimab?

Does anyone find it "interesting" that requests for approvals in Canada have been slow walked or abandoned?

Does anyone find it "interesting" that the name leronlimab is rarely mentioned on network television?

Does anyone find it "interesting" that CytoDyn is handed not one but two rare warning letters by the FDA. One such letter had no identified author.

Does anyone find it "interesting" that a Covid-19 trial was effectively neutered due to under treatment of patients for weeks?

Does anyone find it "interesting" that a long hauler trial has been slow walked for six months?

Does anyone find it "interesting" that age disparity was discovered in a Covid trial which skewed the results?

Does anyone find it "interesting" that CYDY stock is one of, if not THE most shorted stock?

Does anyone find it "interesting" that CYDY's major CRO for some unexplained reason failed to abide by FDA direction in administering CytoDyn trials?

Does anyone find it "interesting" that a couple dozen fake law firms publicly advertised "investigations" of CytoDyn?

Does anyone find it "interesting" that dozens of forum bashers concentrate endless detrimental attacks every day for years?

Does anyone find it "interesting" that remdesivir was given approval not because it hit its endpoints, but because it was "trending"?

Does anyone find it "interesting" that in spite of what appears to be a blockbuster treatment for multiple indications, no one cares.